已收录 272983 条政策
 政策提纲
  • 暂无提纲
Development and Validation of RP-HPLC Method for the Simultaneous Determination of Amiloride Hydrochloride and Furosemide in Pure and Pharmaceutical Dosage Form
[摘要] A simple, selective, rapid, precise and economical reverse phase high performance liquid chromatographic method has been developed for the simultaneous estimation of Amiloride Hydrochloride and Furosemide from pharmaceutical formulation. The method was carried out on an Enable C18 (250x4.6) mm; 5 µm with a mobile phase consisting of acetonitrile:  Water (adjusted to pH 4 using orthophosphoric acid) in the ratio of 70:30 v/v at a flow rate of 1.0 ml/min.  Detection was carried out at 281nm.  The retention times of Amiloride Hydrochloride and Furosemide were 2.21 min. and 7.60 min., respectively. The developed method was validated according to ICH guidelines for evaluation of accuracy, precision, linearity, limit of detection, limit of quantitation and robustness. The proposed method can be used for the estimation of these drugs in combined dosage form.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 分析化学
[关键词] RP-HPLC;amiloride hydrochloride (AML);furosemide (FUR) [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文